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Abstract
DNA methylation of CpG islands plays a crucial role in the regulation of gene expression. More than half of all human
promoters contain CpG islands with a tissue-specific methylation pattern in differentiated cells. Still today, the whole
process of how DNA methyltransferases determine which region should be methylated is not completely revealed. There
are many hypotheses of which genomic features are correlated to the epigenome that have not yet been evaluated.
Furthermore, many explorative approaches of measuring DNA methylation are limited to a subset of the genome and thus,
cannot be employed, e.g., for genome-wide biomarker prediction methods. In this study, we evaluated the correlation of
genetic, epigenetic and hypothesis-driven features to DNA methylation of CpG islands. To this end, various binary classifiers
were trained and evaluated by cross-validation on a dataset comprising DNA methylation data for 190 CpG islands in
HEPG2, HEK293, fibroblasts and leukocytes. We achieved an accuracy of up to 91% with an MCC of 0.8 using ten-fold cross-
validation and ten repetitions. With these models, we extended the existing dataset to the whole genome and thus,
predicted the methylation landscape for the given cell types. The method used for these predictions is also validated on
another external whole-genome dataset. Our results reveal features correlated to DNA methylation and confirm or disprove
various hypotheses of DNA methylation related features. This study confirms correlations between DNA methylation and
histone modifications, DNA structure, DNA sequence, genomic attributes and CpG island properties. Furthermore, the
method has been validated on a genome-wide dataset from the ENCODE consortium. The developed software, as well as
the predicted datasets and a web-service to compare methylation states of CpG islands are available at http://www.cogsys.
cs.uni-tuebingen.de/software/dna-methylation/.
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Introduction
DNA methylation of differentiated cells in mammals occurs
almost exclusively at the C5 position in cytosine when it is
immediately followed by a guanine [1]. The methylation of the
59–CG–39pairisrelatedtochromatinremodelingeffectsandmostly
resultsinsilencingofdownstreamgenes[2,3].CpGsaresignificantly
enriched insome partsof thegenome, comparedto the average CG
content of the whole genome. These CpG enriched genome parts
are called CpG islands [4]. CpG islands are usually detected
computationally, e.g., by applying certain constraints on the
occurrence of CpGs in a sequence window [5]. More recent
approaches try to include further data and conditions to get better
predictionsofCpGislandsinthegenome[6].Therefore,depending
onthechosenapproachandconstraints,thenumberofCpGislands
inthehumangenomevaries.However,itisknownthatCpGislands
occur in 50 to 60 percent of all human promoters and in all
promoters of human housekeeping genes [7–9].
These CpG islands are mostly unmethylated and therefore
represent a markable exception to the almost globally methylated
genome [7,10]. Today, it is known that different tissues and cell
lines have specific methylation profiles [11–14]. These profiles are
inherited by epigenetic mechanisms which are not completely
understood [15]. Though, there are some recent evidences that
DNA methylation profiles during early development of cells is
probably mediated through histone modifications [10]. However,
not only different tissues exhibit a specific methylation profile but
also diverse diseases are suspected to have specific alterations of
the usual methylation profile [16]. Especially in cancer, DNA
methylation is supposed to play a key role for the repression of
tumor suppressor genes [17–19]. Due to the large amount of
different tumor types, cell lines and tissues with each having an
own methylation profile, many explorative approaches to de-
termine the DNA methylation status are required. A common way
to experimentally perform DNA methylation analyses by hand is,
to employ bisulfite sequencing and focus only on selected genomic
regions [20,21]. Prediction methods that extend data to the whole
genome can be employed to reduce the experimental costs and
speed up the methylation detection process [22–24]. But more
important, they can be used to gain insights of the DNA
methylation process. For example, they can reveal which features
are of influence for a specific methylation pattern of a particular
tissue or disease. These prediction methods need numeric features
to distinguish between methylated and unmethylated CpG islands.
The search for features to predict the methylation status of CpG
islands started with Feltus et al. [25], who used general CpG island
attributes (such as CG content, CG observed/expected ratio, etc.)
and static sequence motifs as features. Das et al. [26] additionally
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features. Fang et al. [27] extended the prediction of transcription
factor binding sites from motifs to position frequency matrices and
used them as features. So far, only purely sequence based features
have been used. Bock et al. [28] were the first to introduce new
kinds of features. In addition to the features from previous
approaches, they used repeat frequencies and distributions, CpG
island frequencies and distributions, predicted DNA structure,
gene and exon distribution, evolutionary conservation, and SNPs.
Later approaches did not introduce more relevant features to the
prediction of CpG island methylation, except for Fan et al., who
successfully used histone modification marks for this task [29].
Apart from these methylation prediction approaches, several
research groups suggested some distinctive features based on their
studies. For example, the distance to the transcription start site,
periodic distributions of CpGs in methylated CpG islands, flanking
sequences of methylated CpGs, or tissue-independent correlation
of histone modification profiles and DNA methylation
[10,20,21,30,31].
In this study, we used data from the NAME21 consortium [21]
to assess the accuracy of different prediction algorithms (see
Table 1) and the predictive performance of different genomic and
epigenomic features (see Table 2 for a complete list). For this
purpose, we created and analyzed feature sets for four different cell
types, consisting of nearly all features from previous approaches,
new findings of recent studies, and completely new features.
Afterwards, we extended the given data from chromosome 21 for
HEPG2, HEK293, leukocytes and fibroblasts to a whole-genome
catalogue of DNA methylation in human and developed
a webservice that allows viewing the results and comparing them
between the different cell types. Furthermore, we validated our
method on a dataset from the ENCODE consortium [32] and
released a stand-alone application for generating the described
feature sets.
Results and Discussion
This study is based on data from Zhang et al., who
experimentally determined the methylation status of 190 CpG
islands on chromosome 21 using 297 amplicons [21]. We
extracted data for DNA methylation of CpG islands from this
dataset for four cell types: leukocytes, fibroblasts, HEPG2 and
HEK293. For each CpG island in each cell type, we calculated
values for the following feature classes separately as described in
the methods section: (1) distances to transcription start sites, (2)
CpG island-specific attributes (e.g., CG content, CG ratio), (3)
genomic attributes (e.g., number of surrounding exons, tran-
scripts), (4) repeat, Alu-Y and DNA/DNA alignment features, (5)
single nucleotide polymorphisms (SNPs), (6) periodic CpG
distances, (7) closest CpGs, (8) sequence - dinucleotides, (9)
sequence - tetranucleotides, (10) CpG flanking sequence, (11)
splice sites, (12) transcription factor binding sites, (13) DNA
structure, (14) evolutionary conservation, (15) histone modification
data. Using the complete set of features, we applied the following
machine learning algorithms to assess their performance on CpG
island methylation prediction: (A) decision trees (J48), (B) naive
Bayes, (C) k-nearest neighbor, (D) K* [33], (E) random decision
forest, (F) and support vector machines with Gaussian radial basis
function and (G) linear kernel. To ensure a fair comparison, all
analyses have been repeated ten times with a ten-fold cross-
validation. Model selections have been performed for each
classifier, if required. Using the most accurate classifier, we
evaluated the suitability of all 15 feature classes for predicting
DNA methylation of CpG islands. To this end, we trained and
evaluated support vector machines with RBF kernel for all 15
feature classes and four cell types separately and evaluated their
performance. With these results in hand, we extended the existing
methylation data to the whole genome, by predicting the unknown
methylation status of all CpG islands in the human genome. To
further evaluate the generalizability of our method, we took
a whole-genome DNA methylation dataset from the ENCODE
consortium [32] and trained our classifier on all CpG islands from
chromosome 21. We achieved an accuracy of 90%, while
predicting the remaining chromosomes and comparing the
predicted to the experimental methylation state.
Machine Learning Algorithms
Table 1 summarizes the performance of each machine learning
algorithm. To ensure a fair comparison of different algorithms and
kernels, model and parameter selections have been implemented
for all algorithms, as required. All values are an average of ten
repetitions of ten-fold cross-validations. Support vector machines
(SVMs) outperformed other machine learning techniques in most
datasets. We could not measure a significant difference between
linear and radial basis function (RBF) kernels across all cell types.
Since the explanatory power of the accuracy relies strongly on the
underlying distribution (count of methylated and unmethylated
CpG islands), we used Matthews correlation coefficient (MCC) for
comparing the machine learning algorithms. The maximal
correlation coefficient achieved is 0.825 when predicting the
methylation status of leukocytes with a linear kernel. In general,
SVMs outperformed other machine learning approaches in our
comparison. However, we could not measure a significant
difference between RBF and linear kernels across all cell types.
The second best classifiers according to Table 1, are random
decision forest and the k-nearest neighbor (kNN) algorithm. In
essence, kNN is based on measuring the numerical distance of
feature values to methylated or unmethylated instances and
assigning the state of the closer instance. The good performance of
this algorithm indicates that certain features must be correlated to
DNA methylation. This again supports the assumption that there
are DNA- and sequence-related features that increase the
probability that cytosines are getting methylated. Furthermore,
Table 1 shows that K*, and naive Bayes are not suitable for good
DNA methylation predictions. Decision trees show a decent
performance in HEK293 and Leukocytes, but fail to predict the
Table 1. Machine learning algorithm performance.
HEPG2 HEK293 Leukocytes Fibroblast
LIBSVM (RBF
kernel)
0.54360.30 0.71660.01 0.80160.02 0.63560.19
LIBSVM (linear
kernel)
0.38260.24 0.74360.17 0.82560.14 0.56460.18
Random Decision
Forest
0.36360.28 0.66760.19 0.76560.18 0.33360.32
kNN 0.38360.27 0.65460.19 0.68360.21 0.40760.28
Decision tree (J48) 0.20460.24 0.52660.20 0.62960.26 0.21460.30
K* 0.12860.33 0.38160.36 0.39360.36 0.31260.40
Naive Bayes 0.05760.21 0.11760.26 0.14660.22 0.06460.24
Performance comparison of different machine learning algorithms for the task
of DNA methylation prediction. We measured Matthews correlation coefficient
(MCC) for every algorithm and every cell type using all features. The values
shown in this table are the average of ten repetitions using ten-fold cross-
validation.
doi:10.1371/journal.pone.0035327.t001
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accurately predict DNA methylation on unknown datasets.
Features
To evaluate the predictive performance of our features and to
analyze, which conditions make cytosines more prone to getting
methylated than others, we divided the generated set of features.
One feature set was created for every cell type and every feature
class, resulting in 4.15=60 feature sets. We performed each
experiment for every feature set using support vector machines
with RBF kernel. The performance for each class of features in
each cell type is shown in Table 2. Figure 1 gives an impression
which genomic and non-genomic features are correlated to DNA
methylation across all cell types. Taking the accuracy as a measure
of performance is not recommended, because the underlying data
is unbalanced. Thus, assigning all CpG islands the unmethylated
state would result in an accuracy between 60% and 74%. A better
measure is the MCC, since it takes both states (methylated and
unmethylated) equally into account and is thus independent of the
class distribution. An MCC of -1 denotes a perfect inverse
prediction, whereas an MCC of 1 denotes a perfect prediction. An
MCC of 0 corresponds to an average random prediction
independent of the underlying class distribution. In this section,
we are going to report and discuss all features in order of their
predictive power. This is the same order as they appear in the
referenced tables and figures.
The best average performance is achieved when using all
features. This confirms a correlation of DNA methylation to
features from different categories. Nearly the same performance is
achieved when using exclusively the histone modification feature.
This indicates that DNA methylation of CpG islands is strongly
correlated to histone modifications as previously suggested by
several other studies [29,34,35]. This result is also a confirmation
of the proposed method, since recent studies have shown that the
basic DNA methylation profile during early development is
probably mediated through histone modifications [10,36].
Before establishing the tissue-specific DNA methylation profile,
some genomic regions are wrapped around nucleosomes that
contain methylated lysine 4 of histone H3 (mono-, di- or
trimethylation - H3K4me). Other nucleosomes contain unmethy-
lated H3K4. This methylated H3K4me mark prevents de novo
methylation of CpG islands in the embryo [10]. Since these
findings are tissue-independent, other researchers have detected
inverse relations between DNA methylation and H3K4me or
H3K27me for multiple cell types [37,38]. The histone modifica-
tion dataset used in this study (that includes separate data for
H3K27 and H3K4 mono-, di- and trimethylation) has been
measured in human CD4 T-cells. The strong predictive
performance of this feature class across all cell types supports
these recent findings and confirms that H3K4me marks dictates
methylation of CpG islands across several cell types. Another
strong correlation exists between DNA structure and methylation.
This has already been confirmed in other prediction approaches
[28,39]. Bock et al. report that the DNA rise (displacement
between two base pairs along the helix axis) increases generally in
CpG islands, compared to other genomic regions, while the DNA
twist (amount of rotation between two base pairs around the helix
axis) decreases. Methylated CpG islands seem to enhance this
effect and have a much higher difference in DNA rise/twist than
unmethylated CpG islands. Interestingly, this feature class per-
forms in all different cell-types nearly as well as histone
methylation marks.
Typical feature classes, that have already been used by the first
CpG island methylation prediction approaches, are DNA
Table 2. Single feature class performance.
Feature name HEPG2 HEK293 Leukocytes Fibroblast
ACC MCC ACC MCC ACC MCC ACC MCC
All features 0.85 0.54 0.87 0.72 0.91 0.80 0.87 0.64
Histone modification data 0.83 0.52 0.83 0.66 0.91 0.82 0.86 0.68
DNA structure 0.82 0.47 0.85 0.68 0.85 0.67 0.83 0.53
Sequence - dinucleotides 0.80 0.34 0.86 0.70 0.89 0.76 0.82 0.54
CpG island-specific attributes 0.79 0.41 0.86 0.69 0.87 0.71 0.81 0.50
Sequence - tetranucleotides 0.78 0.34 0.86 0.69 0.89 0.75 0.79 0.45
Genomic attributes 0.82 0.47 0.83 0.63 0.82 0.60 0.81 0.49
Transcription factor binding sites 0.81 0.41 0.80 0.58 0.85 0.65 0.82 0.48
Closest CpGs 0.82 0.43 0.78 0.52 0.81 0.56 0.82 0.45
Distances to transcription start sites 0.76 0.19 0.72 0.40 0.73 0.36 0.77 0.24
Periodic CpG distances 0.76 0.26 0.67 0.27 0.73 0.38 0.76 0.20
Single nucleotide polymorphism (SNP) 0.77 0.23 0.67 0.27 0.71 0.31 0.78 0.27
Splicing sites 0.80 0.35 0.65 0.19 0.72 0.34 0.77 0.15
CpG flanking sequence 0.79 0.32 0.68 0.29 0.65 0.13 0.78 0.28
Evolutionary conservation (PhastCons) 0.78 0.16 0.65 0.26 0.68 0.21 0.77 0.18
Repeat, ALU-Y and DNA/DNA alignment features 0.76 0.11 0.65 0.23 0.68 0.22 0.77 0.08
Unmethylated instances [%] 0.74 0.60 0.65 0.74
Comparison of predictive performances of single feature classes. All values are taken from SVM predictions with feature files that only contain features belonging to the
given class. Each prediction is an average of a ten-fold cross-validation with ten repetitions. The table shows the accuracy (ACC) and Matthews correlation coefficient
(MCC) for each cell type and each feature class and is sorted by average MCC. Please note that the underlying data is imbalanced (because CpG islands tendt ob e
unmethylated) and the average accuracy when assigning all CpG islands the unmethylated state is 0.71.
doi:10.1371/journal.pone.0035327.t002
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attributes (such as CG content, CG observed/expected ratio,
etc.) [25,26]. They have been proven to be good features for
discriminating between methylated and unmethylated CpG
islands. Using just the dinucleotides, classification of methylated
CpG islands in some cell types is even superior to the DNA
structure feature class. This again confirms the strong correlation
between DNA sequence and methylation. Genomic attributes and
transcription factor binding sites also have a good correlation to
DNA methylation. Genomic attributes include, e.g., the number of
exons overlapping with the CpG island and it has been shown that
exons tend to be higher methylated than introns [40,41]. Thus,
this is an evident feature for DNA methylation predictions. Using
Transcription factor binding sites (TFBS) to predict DNA
methylation of CpG islands has been introduced by Fang et al.
[27]. We calculated the binding scores of 1539 potential
transcription factors in all CpG islands of our input dataset. 456
of those had significant binding scores. Those have been taken to
calculate the features and measure their correlation to DNA
methylation. We observed that there are no single transcription
factors with a high correlation to DNA methylation, whereas the
entirety of all TFBS in this class has a good prediction score. TFBS
are typically modeled by creating position frequency matrices for
target sequences of a transcription factor. As a result, TFBS mainly
depend on the underlying DNA sequence. Thus, having in mind
that DNA sequence, in general, is a good discriminator for CpG
island methylation, it is possible that the correlation between DNA
methylation and TFBS is simply due to the underlying DNA
sequence.
The periodic CpG distances features are based on hypotheses of
Jia et al. and Zhang et al. [21,30]. Both reported that if CpGs inside
a CpG island occur at distances of approximately x.9 base pairs
(1ƒxƒ5), the CpG island tends to be methylated. Based on these
findings, we added features reflecting this hypothesis. But our
research shows that this hypothesis is not suitable to discriminate
between methylated and unmethylated CpG islands. We further
investigated this hypothesis by adding a novel, more generalized
feature class, i.e., the average distance between CpGs in CpG
islands. These features perform slightly better than considering
only multiples of nine, but should still be combined with other
feature classes to get overall good predictions. Another hypothesis-
driven feature class is the noticeable hypomethylation when
approaching transcription start sites (TSS). Eckhardt et al. reported
an almost unmethylated core region of about 61000 bps of each
TSS [20] and Zhang et al. propose that CpG islands, overlapping
a TSS, are mostly unmethylated in differentiated cells [21]. Our
research shows that this feature is not generalizable. This means
that a CpG island is more likely to be unmethylated when it is
close to a TSS, but it does not mean anything if it is not. Probably
just like this feature class, other feature classes only come into play
in special conditions but are not eligible for predicting the
methylation status of CpG islands genome-wide.
Figure 1. CpG island methylation predictions with individual feature classes reveal, which features are correlated to the
epigenome. The figure shows the predictive performances of feature classes, averaged across HEPG2, HEK293, leukocytes and fibroblasts. It reveals,
which features are correlated to DNA methylation and which are unlikely to be related to DNA methylation. Each value is an average of a ten-fold
cross-validation with ten repetitions. The figure shows the accuracy (ACC), Matthews correlation coefficient (MCC) and the area under the receiver
operating characteristic curve (AUC) and is sorted by average MCC.
doi:10.1371/journal.pone.0035327.g001
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methylation and single nucleotide polymorphisms (SNPs) and
conclude that there is no general relation between those. The same
holds true for correlations between DNA methylation and splicing
sites. But, for SNPs, it might be possible to use them as specific
predictors for DNA methylation, if the data is obtained from the
same samples (see, e.g., Bell et al. [42]). Evolutionary conservation
is a feature which seems to be correlated to DNA methylation,
because CpG islands are evolutionarily conserved regions. This
feature is probably more appropriate to detect CpG islands itself,
but not for the methylation state. The so called PhastCons, which
have previously been included by other groups [28,39], did not
perform well in our study. Another controversial hypothesis-driven
feature is the flanking sequence preference of DNA methylating
proteins. Several groups reported different flanking sequence
preferences of CpGs that makes them more prone for getting
methylated [21,31,43]. In our studies, trying to predict the DNA
methylation status by flanking sequence preference does not lead
to good results. However, this does not mean that there is no
flanking sequence preference. For example, Oka et al. [44]
experimentally confirmed the results by Handa et al. [31] and
detected a flanking sequence preference of DNMT3A. Overall,
one has to consider that de novo methylation of DNA is performed
by the DNA methyltransferase enzymes DNMT3A and DNMT3B
complexed with DNMT3L [10]. Comparing this low number of
DNA methylating enzymes with the number of CpGs in the
human genome, one can imagine that it is very hard to derive
specific flanking sequences to discriminate between methylated
and unmethylated CpGs. Because, even when trying to derive
flanking sequences for every enzyme separately, one would have to
divide the set of all CpGs in only three classes: methylated by
DNMT3A, methylated by DNMT3B and unmethylated. Hence,
our studies show that there is no general flanking sequence, which
makes certain CpGs more prone to methylating proteins than
others.
Table 2 shows that the absolute predictive performance of some
feature classes varies between different cell types. This could be
due to technical reasons, like the variability in the number of
training instances between the different cell types, or the varying
ratios between methylated and unmethylated CpG islands. It is
also possible that these deviations come from biological reasons,
e.g., in some cell types, different features are more correlated to
DNA methylation than in others. But, Table 2 also shows that the
relative predictive performance of all feature classes is fairly
consistent for all cell types. Thus, in case of DNA methylation
predictions for novel datasets, we recommend a union of the best
performing feature classes: histone modification data is always
recommended, but might sometimes not be available. The DNA
structure feature set can be calculated from the sequence alone,
same holds true for the dinucleotides, CpG island specific
attributes and Closest CpGs. These attributes, together with the
genomic attributes features, form a good set for novel predictions.
All features sets below Closest CpGs (see Table 2) are not
recommended, because they are too inaccurate. The tetranucleo-
tides are redundant to the dinucleotides. The transcription factor
binding sites might be included in novel feature sets, but they are
slower and more difficult to calculate, compared to the other
sequence-based features.
Prediction of CpG Island Methylation Status
We downloaded the coordinates of all CpG islands in the
human genome from UCSC [45]. With the whole feature dataset
for every cell type, we trained SVMs and took the best parameters
to predict the methylation status of all CpG islands in the human
genome. The methylation landscape of each cell type across the
whole genome is visualized in Figure 2. We have set up
a webservice at http://www.cogsys.cs.uni-tuebingen.de/
software/dna-methylation/that allows users to select one or two
cell types, a chromosome number and then view or compare the
methylation status of CpG islands. This webservice includes all
experimental data in the NAME21 and HEP datasets. Addition-
ally, all predicted data for the cell types measured in the NAME21
data have been included. The webservice allows users to compare
the CpG island methylation status of two cell types by
distinguishing between CpG islands that are methylated, un-
methylated and differentially methylated in both cell types. The
data can be visualized using the UCSC genome browser [46]. An
approximate score is generated for each prediction that represents
the certainty of the prediction. In other words, this score represents
the distance to the SVM hyperplane as per mille of the maximum
predicted distance.
Validation
To further assess the generalizability of our method (SVMs with
RBF kernel, using all described features), we evaluated it on
a whole-genome DNA methylation dataset from the ENCODE
consortium [32]. Briefly, we mapped the probes to CpG islands
(resulting in 17,588 instances), trained our classifier with cross-
validation on a subset of the data and used the resulting model to
predict the methylation state of the remaining CpG islands (more
details can be found in the methods section). Afterwards, we
counted the confusion matrix by comparing the experimentally
determined methylation state with the predicted methylation state
of all CpG islands that have not been used for the training.
Depending on the size of the training and validation set, we
achieved accuracies between 87.2% (trained on 10% of the data)
and 92% (trained on 50% of the data), and MCCs from 0.48
(10%) to 0.58 (50%). Thus, predictive performance of the method
increases with the size of data, available for training. To validate
our NAME21 predictions, we further composed a training set,
consisting of all CpG islands in chromosome 21 (resulting in 224
instances for which we had data in out validation dataset).
Afterwards, we predicted with this model a validation set,
consisting of all CpG islands in other chromosomes and compared
the results to the experimentally determined methylation state.
This resulted in an accuracy of 90% and an MCC of 0.43. Please
see Table 3 for more detailed results on these validation runs.
Evaluation of a Quantitative Prediction Approach
To explore the possibility of a quantitative DNA methylation
prediction approach, we also employed support vector regression
(SVR) models. Briefly, a SVR model is trained by using the actual
methylation percentage of a CpG island instead of the binary
distinction between methylated and unmethylated CpG islands.
Consequently, these regression models return a methylation
percentage, instead of a binary attribute. To assess the suitability
of this classifier, we used the ‘‘GM12878 - replicate 10 dataset from
the ENCODE consortium [32] and processed it as described in
[sec:mm:validation]the validation subsection of the methods
section. We trained our classifier on 10% of the data and
predicted the remaining 90%. For evaluating these quantitative
models, error rates measuring the average difference between the
actual and the predicted values are usually employed. We used the
average absolute error (AAE) for performance evaluations (see
Equation 1) and achieved an AAE of 0.117. This means that each
predicted CpG island methylation value deviates on average by
611.7%.
Predicting CpG Island Methylation States
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that the genome-wide average methylation of our input dataset is
only 9%, the SVR failed to successfully predict the few
hypermethylated CpG islands. However, instead of predicting
the actual amount of methylated CpGs in a CpG island, it is more
useful to predict the binary methylation state of it. For example, if
a CpG island is 80% methylated, it most likely suppresses gene
expression, whereas it is very unlikely to suppress gene expression
with 20% of all CpG’s being methylated. Thus, comparing the
results of the SVR with our binary classifier validations, binary
predictions of CpG island methylation are more accurate and lead
to more meaningful results.
Performance Comparison with Other Approaches
Comparing the performance of different methylation prediction
approaches is difficult, because the procedure is usually a multi-
step workflow (extracting CpG island coordinates, extending them,
generating features, choosing a machine learning approach,
performing the model selection, etc.) and there is no stand-alone
application which can be requested from the authors of other
published methods to make a fair comparison. Furthermore, some
methods are tailored to a specific dataset and there is no standard
operating procedure that can be used for performance compar-
ison. Thus, the comparison has to be done by using the same input
data and evaluation technique of those, who previously published
methylation prediction results. Unfortunately, many datasets are
not available anymore. We were unable to obtain a human brain
dataset, used in Das et al. [26] and Fang et al. [27]. Further on,
Bock et al. [28] and Fang et al. used data from the HEP pilot phase.
Unfortunately, there is only data from the production phase of the
HEP project available. Fan et al. [29] used a leave-one-out cross-
validation statistic to validate their dataset, what makes their
results hard to compare to others, because most other approaches
are using a ten-fold cross-validation. However, the methylation
prediction approach of Bock et al. is one of the latest approaches
and probably the approach with highest impact. The CpG island
coordinates of the training dataset and methylation states for
human blood lymphocytes, used by Bock et al., are publicly
available. Furthermore, they also used support vector machines,
which again makes their results well comparable to ours. Thus, we
decided to make a comparison to Bock et al., and add other
approaches, who also published a comparison to Bock et al., to our
table.
We took the CpG island coordinates and the binary methylation
state of the human blood lymphocytes dataset and lifted them to
the NCBI 36 release of the human genome. Afterwards, we
generated features and trained SVMs exactly as we did for the
NAME21 data. The prediction results of our and other methods
are shown in Table 4. Our maximal prediction accuracy on their
dataset is 95.76% compared to 91.5% of Bock et al. and our
maximum correlation coefficient is 0.87, compared to 0.74. This
reflects the quality and suitability of the features used in our
approach. For example, Bock et al. did not use the histone
modification profiles, which are the best performing feature class
in our approach. We also added the results of a comparison on the
HEP pilot phase data to Table 4. Please note that comparisons on
Figure 2. Predicted whole-genome methylation landscape for all four cell types. This figure visualizes the methylation landscape in all four
cell types, compared to the total number of CpG islands. One bar represents the number of methylated instances per cell type as percentage of the
total number of CpG islands in the given chromosome. The largest number of methylated CpG islands can be found in HEK293, whereas HEPG2 have
an almost unmethylated genome. The few CpG islands in chromosome Y are hypermethylated in most cell types, compared to the other
chromosomes.
doi:10.1371/journal.pone.0035327.g002
Table 3. Validation on experimental data.
Trained
on
Total
CGIs
CGIs in training
set
CGIs in test
set ACC MCC
CHR21 17588 224 17364 90.01 0.43
10% 17588 1758 15830 87.18 0.48
25% 17588 4397 13191 91.68 0.56
50% 17588 8794 8794 92.02 0.58
Validation of the proposed method (SVMs with RBF kernel, using all described
features) on experimental data. The experimental dataset has been divided into
a training and a test set. The training set was used for training and the test set
exclusively for the comparison with prediction results and calculation of
accuracy (ACC) and Matthews correlation coefficient (MCC). We performed this
evaluation on four different training datasets: consisting of all CpG islands
(CGIs) from chromosome 21, randomly picked 10%, 25% and 50% of the data.
doi:10.1371/journal.pone.0035327.t003
Predicting CpG Island Methylation States
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35327HEP data are popular but not recommended, because most
amplicons they used do not fulfill CpG island criteria defined by
Gardiner et al. [5]. This difficulty with the HEP data is also
confirmed by Bock et al. and should be considered when
comparing different approaches.
The Application
The Java application that has been developed to preprocess the
input datasets and generate the features for this study is available
at http://www.cogsys.cs.uni-tuebingen.de/software/dna-
methylation/. This page also holds a documentation for the
application, as well as example datasets, and the predicted
methylation states for the NAME21 dataset. The application can
read tab-separated files, containing probe or CpG island locations
and methylation intensities. It can map probes to CpG islands, lift
coordinates between different releases of the human genome and
generate features for all 15 mentioned feature classes. The
generated feature file can then be used with various machine
learning applications (e.g., LIBSVM [47]) to train a model and
evaluate classifiers or feature classes.
Materials and Methods
Datasets
This study is based mainly on a CpG island methylation dataset
fromtheNAME21Consortium.Thedataset,publishedbyZhanget
al., is freely available [21]. Zhang et al. took the promoter regions of
all protein coding genes on chromosome 21 in Homo sapiens, applied
a window from 2000 bps upstream to 500 bps downstream of the
transcriptionstartsiteandsearchedforCpGenrichedregions,using
the Takai-Jones criteria [48]. These CpG islands have been
analyzed in five different cell types: HEPG2 - a hepatocellular liver
carcinoma cell line, trisomic fibroblasts - derived from an individual
with Down syndrome, HEK293 - a human embryo kidney cell line,
fibroblasts, andleukocytes. The methylation status ofeverycytosine
has been determined using overlapping amplicons, in a way that
most CpGs are covered by multiple amplicons, resulting in 297
amplicons for 190 genes. On the experimental side, they used
bisulfite conversion and subclone sequencing to detect methylated
CpGs [49]. We took their raw data and parsed it into a cell type
specific data structure of CpG islands and CpGs. Methylation
information from multiple amplicons for single CpGs have been
averaged. To determine the methylation status of a CpG island, we
averaged the methylation status of all CpGs in that CpG island and
considered it methylated, if this value is above 60% (same threshold
as in Bock et al. [28]).
After applying these constraints, our dataset consists of 56
methylated (112 unmethylated) instances for leukocytes, 73
methylated (117 unmethylated) instances for HEK293, 44
methylated (142 unmethylated) instances for HEPG2, 43 methyl-
ated (142 unmethylated) instances for fibroblasts, and 32
methylated (137 unmethylated) instances for trisomic fibroblasts.
During evaluation of these datasets, we decided to remove the
trisomic fibroblast dataset for this study, because it contains only of
32 methylated CpG islands with 81% of all CpG islands being
unmethylated. The low number of training samples in this highly
imbalanced dataset made it unsuitable for reliably train support
vector machines with a ten-fold cross-validation.
We extended the sequence to analyze for each CpG island from
the given coordinates by the primer sequence length and 500 bps
up- and downstream to also cover nearby effects, which might
have an influence on cytosine methylation. For example, cis-acting
transcription factors might lie in the sequence, flanking the CpG
island [25]. This window size has also been chosen by Fan et al.
[29] and approved as a good choice by Fang et al. [27]. We
double-checked the data by retrieving every single CpG island
sequence from Ensembl and comparing it to the sequence given in
the source data.
Furthermore, we used two datasets from the ENCODE
consortium [32] to evaluate a quantitative DNA methylation
prediction approach and to validate our method. For the
quantitative DNA methylation prediction approach, we used the
‘‘ENCODE HudsonAlpha Methyl27 GM12878 replicate 10
dataset [50] and to validate our method, the ‘‘ENCODE
HudsonAlpha MethylSeq HEPG2, Pcr2x, replicate 10 dataset
[51] has been used.
Machine Learning Algorithms and Scoring
In order to evaluate the predictability of our features, various
machine learning algorithms have been considered. We used
support vector machines (SVMs) with linear and radial basis
function (RBF) kernels, decision trees, naive Bayesian networks, k-
nearest neighbor, random decision forest and the K* (KStar)
classifier.
With each of these machine learning algorithms, we assessed the
predictive performance using the complete feature dataset for each
cell type separately. The accuracy, Matthews correlation co-
efficient (MCC) and the area under the receiver operating
characteristics curve (AUC) have been calculated for each
prediction. The accuracy is the percentage of all predictions that
are correct. The MCC is a performance measure that is especially
suited for imbalanced binary datasets. It calculates a correlation
coefficient between -1 (perfect inverse prediction) and 1 (perfect
prediction), where 0 is an average random prediction independent
of the underlying class distribution. This is a good measure for
DNA methylation predictions because CpG islands tend to be
unmethylated. For example, with 71% of all CpG islands being
unmethylated, simply classifying all data as unmethylated would
already result in an accuracy of 71% but the MCC would be 0.
For a detailed discussion on these scoring metrics and their
calculation, please see the work of Baldi et al. [52].
To measure the performance of support vector regression
models, we employed the average absolute error (AAE), which is
an error rate that measures the average difference between the
actual (targeti) and the predicted (predictioni) methylation values
(see Equation 1).
Table 4. Comparison of different methylation prediction
approaches.
Year Authors Dataset CC Accuracy
2006 Fang et al. [27] HEP pilot phase data 0.42 81.48
2006 Bock et al. [28] HEP pilot phase data 0.15 74.76
2006 Bock et al. [28] Human peripheral blood
lymphocytes
0.74 91.5
Our approach Human peripheral blood
lymphocytes
0.87 95.76
Our approach NAME21 (Leukocytes) 0.80 91.13
The predictive results of our method, compared to other methods. The table
shows that our method outperforms other previously published methods.
doi:10.1371/journal.pone.0035327.t004
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All experiments have been performed using a ten-fold cross-
validation. In addition, ten repetitions with different seeds have
been used in all experiments, resulting in 100 experiments, which
were averaged for each reported value. For the SVM predictions
(classification and regression), the LIBSVM [47] and LIBLINEAR
[53] have been used. The WEKA library [54] has been used for all
other classifiers.
Validation
The HEPG2 dataset from ENCODE, used for the validation of
our method, is a binary dataset. It contains sequence regions that
have a score of 0 (unmethylated) or 1000 (methylated). All
sequence regions from this dataset have been mapped to CpG
islands (using coordinates from UCSC) and each CpG island is
assigned a methylation value, based on the average methylation of
all sequence regions, overlapping with the CpG island. Sequence
regions that did not overlap with CpG islands have been
discarded. Afterwards, we removed all differentially methylated
CpG islands from our dataset. For example, if a CpG island has
two overlapping sequence regions and only one of them is
methylated, even with the experimental data we can not decide if
the whole CpG island is methylated or not. Thus, we removed all
CpG islands that are between 40% and 60% methylated.
Afterwards, we separated this dataset into a training and a test
set. This is performed, e.g., by randomly picking 10% of all CpG
islands using a stratified sampling procedure. This means, our
training set has the same percentage of methylated CpG islands as
the whole dataset. For another validation, we simply took all CpG
islands from chromosome 21 into our training set and declared all
CpG islands from other chromosomes as test set. After splitting the
dataset, we trained a support vector machine with RBF kernel,
using all features, ten repetitions and a ten-fold cross-validation on
this training set. With the resulting model, we predicted the
methylation status of the remaining CpG islands and compared
them with the experimentally determined methylation status. This
ensures an accurate validation, because no CpG islands that have
been used to train the method are used to evaluate the predictions.
We used a similar procedure for the evaluation of our
quantitative prediction approach. The GM12878 dataset from
ENCODE, which is a non-binary dataset, has been used for this
purpose. We mapped all sequence regions from this dataset to
CpG islands annotated by UCSC, averaged the methylation
values of all overlapping regions and removed regions that are not
overlapping with CpG islands. We then picked 10% of these CpG
islands as in the HEPG2 ENCODE dataset and evaluated our
regression model by comparing all predicted methylation values
with the experimental methylation values.
Features
If not explicitly stated, all data comes from Ensembl v47. This
Ensembl version is based on the NCBI 36 release of the human
genome. We used coordinates and sequences from the NCBI 36
release for all studies. For all UCSC data, we used the hg18
version (which corresponds to NCBI 36). All features were
calculated on this release of the human genome. We used the
UCSC LiftOver tool (http://genome.ucsc.edu/cgi-bin/
hgLiftOver) to map all data on this release of the human genome.
Our feature dataset consists of 948 features from 15 categories:
1) Distances to transcription start sites (4 features).
Several groups observed that the methylation of CpGs
decreases gradually when approaching the transcription
start site (TSS) of a gene [20,21]. We included this
observation by measuring the distance to the closest gene
and closest protein coding gene, based on the Ensembl
database. Each value has been added normalized and
logarithmized.
2) CpG island-specific attributes (7 features). CG
content, CG ratio, CG observed/expected ratio [5], CG/
TG ratio (with and without the reverse strand), AT/CG
ratio and a boolean flag, if the CpG island is in a coding
region have been added as features.
3) Genomic attributes (11 features). We included the
percentage of repetitive base pairs (CpG island length/total
length of all self-alignments), number of genes overlapping
with the CpG island, total length of all overlapping genes,
number of exons overlapping with the CpG island, total and
average length of all overlapping exons, number of
transcripts for all overlapping genes and number of
transcripts divided by number of overlapping genes. For
completeness: CpG island length, percentage of CpGs in the
whole CpG island and average distance between CpGs have
been added to this category.
4) Repeat, Alu-Y and DNA/DNA alignment features
(19 features). We implemented features, representing
DNA/DNA self alignments in the CpG island region,
various features covering repetitive elements in the CpG
island region (e.g., total number of repeats, length of repeats)
and multiple features analyzing the Alu-Y repeat. This
special AGCT-repeat has been found to occur often in
methylated CpG islands [27,55]. All features were calculat-
ed for three different window sizes: 6900 bp, 6400 bp and
exactly covering the CpG island.
5) Single nucleotide polymorphism (8 features).
Known single nucleotide polymorphisms (SNPs) have been
retrieved from the Ensembl database for various window
sizes, flanking the CpG island. The number of all SNPs and
the distance to the closest SNP from the center of the CpG
island have been added to the feature list. Additionally, the
same values have been calculated especially for T/C SNPs,
because of its special role in bisulfite sequencing [56,57].
6) Periodic CpG distances (15 features). Jia et al.
reported a correlation between DNA methylation and
a periodic distribution of CpGs [30]. They state that if the
CpGs are at a distance of eight to ten base pairs, they are
more likely to be methylated. Zhang et al. validated these
findings and reported a significant enrichment of distances
9, 18 and 27 bps between CpGs in highly methylated
amplicons [21]. Based on these findings, we calculated
distance scores specially for multiples of nine from 9 to
45 bps in both directions of a CpG. While studying the
flanking sequences of methylated CpGs, we realized
a significant difference in CpG occurrence at a distance of
48 bps (CpGs occur almost twice as frequently as on other
positions). For this reason, we added features representing
the CpG occurrence at a distance of 48 bp on both strands,
additionally to the multiples of nine. All values have been
averaged for all CpGs in the CpG island and three
additional features have been added, which represent sums
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of these two sums.
7) Closest CpGs (6 features). In addition to periodic CpG
distances, feature scores have been implemented which
measure the distance to the three closest CpGs in general.
The features are calculated by measuring the distances to
the three closest CpGs for all CpGs in a CpG island. The
three smallest and the average of all values are added as
features.
8) Sequence - dinucleotides (16 features). We counted
the occurrences of all possible 16 dinucleotides in the CpG
island sequence and added these values, divided by the CpG
island length as features.
9) Sequence - tetranucleotides (257 features). We did
the same for all 256 tetranucleotides. This also covers the
four base pair long Alu repeat (for which we also added an
additional feature that represents the total, not averaged
count of Alu repeats). Please note that combining this feature
class with the dinucleotides feature class might lead to
redundancies in the resulting feature set.
10) CpG flanking sequence (4 features). Several authors
claim to have found flanking sequences for DNA methyl-
transferases [21,31,43]. This means that methylated CpGs
have other flanking sequences than unmethylated CpGs.
Zhang et al. report that A/T nucleotides tend to occur more
often in flanking sequences of methylated CpGs, whereas C/
G flanks occur more often when the CpG pair is
unmethylated [21]. We took the flanking sequences 64b p
and 620 bp for all CpGs in the dataset. We separated these
into methylated and unmethylated CpGs and calculated
position frequency matrices (PFMs) [58] for all these
sequences and for every cell type separately as follows:
Calculate a PFM for all methylated instances and a PFM for
all unmethylated instances. Divide the PFM of methylated
instances (by dividing the frequency of each nucleotide in
each position) by the PFM of unmethylated instances. This
leads to a total of four PFMs, separating methylated from
unmethylated instances that were used for each cell type:
two PFMs, specific for the cell type, with flanking sequence
sizes of 4 and 20 bp and two non-specific PFMs with the
same flanking sequence sizes. These PFMs have then been
applied to the CpG island sequences and a weight score,
covering the quality of the match and the significance, based
on the frequency of the actual sequence in the whole human
genome [59] is used as a feature. We used ModuleMaster
[60] to apply the PFMs to the sequences and calculate the
weight scores.
11) Splice sites (5 features). We used all four PFMs,
generated from SpliceDB [61] to identify splice sites. The
four PFMs correspond to mammalian frequency matrices of
splice sites for GT-AG and GC-AG pairs for donor and
acceptor sites respectively. These four features were in-
tegrated as weight scores (as described in 10) CpG flanking
sequence). Additionally, the number of hits from all PFMs has
been added as fifth feature.
12) Transcription factor binding sites (457 features).
Correlation between DNA methylation and transcription
factor binding sites (TFBSs) has already been reported by
several groups [20,26–28]. ModuleMaster [60] was applied
to calculate weight scores, as described in 10) CpG flanking
sequence, which we added to our feature database. The
transcription factors have been selected among a large PFM
database, consisting of transcription factor binding in-
formation from TRANSFAC professional, NUBIScan and
predicted TFBSs. This dataset is described in more detail by
Wrzodek et al. [60]. We took all CpG island sequences from
the NAME21 dataset and performed a matrix scan with all
PFMs on those. All PFMs which had a weight score below
one were removed, because of lack of significance (good
matches should have weight scores of at least five. Smaller
scores indicate that either the putative TFBS is not well
recognized by the PFM or that the putative TFBS occurs
very often by chance throughout the human genome). This
resulted in a total of 456 PFMs we took for this study. In
addition to these 456 features, we added the logarithm of the
sum of all TFBSs as feature.
13) DNA structure (43 features). Bock et al. have found
a statistically significant correlation between DNA structure
and CpG island methylation [28]. We used the data from
Gardiner et al. to calculate octamer sequence dependent
predicted DNA structure energies [62] (7th order hidden
Markov models) and added a total of 43 features,
representing these energy values.
14) Evolutionary conservation (4 features). Methylation
patterns tend to be evolutionarily conserved [63]. Siepel et al.
generated PhastCon elements, representing the evolutionary
conversation of a region [64]. We took the data from the
UCSC Genome Browser [45] and generated several
features, representing the evolutionary conservation of the
CpG island.
15) Histone modification data (92 features). The corre-
lation between histone modification and DNA methylation
has already been reported by several authors [10,36,65,66].
Fan et al. already tried to use histone modification marks for
predicting DNA methylation [67] and were quite successful
with it. Barski et al. [29] generated 23 genome-wide datasets,
covering 20 different histone modification variants
(H3K4me1, H3K4me2, H3K4me3, H3K9me1,
H3K9me2, H3K9me3, H3K27me1, H3K27me2,
H3K27me3, H3K36me1, H3K36me3, H3K79me1,
H3K79me2, H3K79me3, H3R2me1, H3R2me2,
H4K20me1, H4K20me3, H4R3me2, H2BK5me1) and
the distribution of H2A.Z, RNA polymerase II, and the
insulator binding protein CTCF. We used this data, mapped
it to each available CpG island and generated four
numerical features for each histone modification dataset
and CpG island. This results in a total of 92 histone
modification features per CpG island. It has been shown
that, e.g., H3K4me prevents DNA methyltransferase
enzymes from de novo methylating CpG islands [10]. Thus,
taking one dataset for all cell types allows for validation of
our method, because some histone modifications dictate
DNA methylation in the embryo.
Prediction of CpG Island Methylation Status
All CpG islands have been downloaded for the hg18 release of
the human genome from UCSC [45]. We generated feature sets
for every CpG island exactly as we did for our training data. The
LIBSVM svm-predict application [47] has been used with all
features to predict the unknown methylation states. Two
parameters (C and Gamma) for the RBF Kernel are necessary
to build a model for the predictions. These have been estimated
for each cell type by performing a grid parameter search on the
experimental data and calculating the ACC, MCC and AUC of
every parameter combination (parameter grids: C: 2{45 to 235,
Gamma: 2{55 to 27, for each step, the exponent has been
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MCC or AUC lies on a border and refined to a smaller step size if
a peak has been found. We took the parameter combination for the
prediction that had the lowest combined score according to
equation 2. In all cases, this score matched the maximal MCC.
Score(i)~(ACCi{max
Vj
(ACCj)
z(MCCi{max
Vj
(MCCj))
z(AUCi{max
Vj
(AUCj))
ð2Þ
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